Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Exec VP Finance, CFO

Chief Executive Officer

Chief Business Officer

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. Salarius Pharmaceuticals, Inc. is headquartered in Houston, Texas.

Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing treatments for cancers with unmet medical ne...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2023-02-13	Premium	acquired	Premium	Premium	Premium	Exec VP Finance, CFO
2023-02-13	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-01-03	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-01-03	Premium	acquired	Premium	Premium	Premium	-
2023-01-03	Premium	acquired	Premium	Premium	Premium	-
2023-01-03	Premium	acquired	Premium	Premium	Premium	-
2023-01-03	Premium	acquired	Premium	Premium	Premium	-
2023-01-03	Premium	acquired	Premium	Premium	Premium	Exec VP Finance, CFO
2023-01-03	Premium	acquired	Premium	Premium	Premium	-
2023-01-03	Premium	acquired	Premium	Premium	Premium	-
2022-11-03	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-11-03	Premium	acquired	Premium	Premium	Premium	Exec VP Finance, CFO
2022-11-03	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-11-03	Premium	acquired	Premium	Premium	Premium	Exec VP Finance, CFO
2022-06-07	Premium	bought	Premium	Premium	Premium	-
2022-06-07	Premium	bought	Premium	Premium	Premium	-
2022-06-06	Premium	bought	Premium	Premium	Premium	-
2022-06-03	Premium	bought	Premium	Premium	Premium	-
2022-05-31	Premium	bought	Premium	Premium	Premium	Exec VP Finance, CFO
2022-05-26	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-05-26	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-05-26	Premium	bought	Premium	Premium	Premium	Chief Executive Officer
2022-05-03	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer

SLRX - Salarius Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for SLRX